Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition for the in vivo production of therapeutic products

Composition for the in vivo production of therapeutic products

US Patent 6464998 · Granted Oct 15, 2002

Estimated economic value: $1,487,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Regulation of gene expression by aptamer-mediated modulation of alternative spli2025
Regulation of gene expression via aptamer-mediated control of self-cleaving ribo2025
Treatment of mucopolysaccharidosis IVA2025
Efficient systemic treatment of dystrophic muscle pathologies2024
Prognostic marker for myeloproliferative neoplasms2023
Regulation of gene expression through aptamer-modulated polyadenylation2023
Regulation of gene expression via aptamer-mediated control of self-cleaving ribo2022
Method of treatment of human papillomaviruses related chronic infections2022
Modified adeno-associated virus vectors and delivery thereof into the central ne2022
Regulation of gene expression by aptamer-mediated modulation of alternative spli2022
TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms2021
Identification of a JAK2 mutation in polycythemia vera2021